logo
LIBOGENE is in the business of cancer molecular diagnosis. The company has established an internationally certified CAP laboratory, and is building a tumor mutant gene databank. LIBOGENE has successfully developed many targeted cancer treatment testing panels and identified novel indigenous tumor resistant gene mutations which can be used as important diagnostic biomarkers.
If you have any questions about our products and services, please input the following details, we will contact you as soon as possible to answer your questions.

繁中  |  简中  |  ENG
 

Services

Our Services
In the new “specific patient, specific symptom” medical age, genetic testing can be used for gene abnormality analysis of gene clusters targeted by cancer drugs for newly diagnosed cancer patients or cancer recurrence patients.

Non-small cell lung cancer gene detection panel

The non-small cell lung cancer gene detection panel detects 16 genes and 75 mutation sites, including specific gene mutations that code for the targets for targeted therapies and tumor resistant gene mutations which can be used as important diagnostic biomarkers. We aim to help physicians identify the right drugs so that treatment effect could be maximized while reducing unwanted treatment-induced side effects.

Details

Colorectal cancer gene detection panel

The colorectal cancer gene detection panel detects 8 genes and 79 mutation sites, including specific gene mutations that code for the targets for targeted therapies and tumor resistant gene mutations which can be used as important diagnostic biomarkers. We aim to help physicians identify the right drugs so that treatment effect could be maximized while reducing unwanted treatment-induced side effects.

Details

Comprehensive cancer gene detection panel

The comprehensive cancer gene detection panel detects 30 genes and 280 mutation sites, including specific gene mutations that code for the targets for targeted therapies and tumor resistant gene mutations which can be used as important diagnostic biomarkers. We aim to help physicians identify the right drugs so that treatment effect could be maximized while reducing unwanted treatment-induced side effects.

Details